Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Bacterial vaginosis Stories

2012-05-02 21:22:13

Scientists hope research is starting point for personalized medicine for women The delicate balance of microbes in the vagina can change drastically over short periods of time in some women, while remaining the same in others, according to a new study led by the University of Maryland School of Medicine's Institute for Genome Sciences and the University of Idaho. The scientists believe that these microbes affect a woman's susceptibility to infection and other diseases, so such changes...

2012-01-05 08:00:00

MedcoSouth Healthcare LLC announces the five year anniversary of its ground breaking product, Femanol. Las Vegas, NV (PRWEB) January 05, 2012 "Femanol® has solved the embarrassing problem of vaginal odor for thousands of women worldwide," says Alice Brown, president of MedcoSouth. Details and order information are available at http://www.femanol.com. "Femanol® is an all natural based product that was developed specifically to eliminate vaginal odor by balancing the good vs. bad...

2011-08-15 07:00:00

MELBOURNE, Australia, Aug. 15, 2011 /PRNewswire-Asia/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced the commencement of its Phase 2 study of VivaGel® for the prevention of bacterial vaginosis (BV), following receipt of ethics approval. The prevention of BV is the second area of investigation of the VivaGel® product for this condition. In May 2011, Starpharma announced the positive results of its first study of...

2011-07-27 06:35:00

HAMILTON, N.J., July 27, 2011 /PRNewswire/ -- Medical Diagnostic Laboratories, L.L.C. (MDL) is a CLIA certified infectious disease laboratory which specializes in high-complexity, state-of-the-art, automated DNA-based molecular analyses. By using molecular techniques, MDL is able to provide clinicians from many different specialties valuable tailored diagnostic information to assist in the detection, diagnosis, evaluation, and treatment of viral, fungal, and bacterial infections. MDL, a...

2011-07-18 14:59:00

MOUNTAIN VIEW, Calif., July 18, 2011 /PRNewswire/ -- Scientists at Osel Inc. and the National Cancer Institute (NCI) have developed a new way to prevent HIV infection by genetically enhancing the ability of naturally occurring vaginal bacteria to block viral transmission. Bioengineered bacteria introduced into the vaginal cavity of macaques--a commonly used experimental primate--reduced the transmission of simian HIV (SHIV) by nearly two thirds. The novel approach takes advantage of...

2011-05-23 00:30:00

SYDNEY, May 23, 2011 /PRNewswire/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced successful results of a major phase 2 clinical study that demonstrated efficacy of VivaGel(R) for the treatment of bacterial vaginosis (BV). Key Points: VivaGel(R) meets primary endpoint, demonstrating significant efficacy for treatment of BV VivaGel(R) expected to avoid many shortcomings of existing therapies Trial results support new patent filing which extends VivaGel(R)...

2010-06-03 16:23:16

Differences seem divided between ethnic groups; Scientists hope research leads to personalized medicine The delicate balance of microbes in the vagina can vary greatly between healthy women, according to a new study led by the University of Maryland School of Medicine's Institute for Genome Sciences. Researchers hope further study will lead to personalized reproductive medicine for women, allowing doctors to tailor each woman's treatment and health maintenance strategies to her individual...

2010-02-04 14:38:11

Study finds association between genes that regulate maternal inflammatory response, bacterial vaginosis and preterm delivery In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting â“ž¢, in Chicago, researchers will show the use of haplotype tagging (hap-tag) single-nucleotide polymorphisms (SNPs) to study the relationship between genetic predispositions, an environmental factor - bacterial...

2009-11-18 08:00:00

MELBOURNE, Australia, Nov. 18 /PRNewswire-FirstCall/ -- Starpharma Holdings Limited (ASX: SPL; OTCQX: SPHRY) is pleased to announce a successful capital raising of A$15.6 million through a private placement to institutional and sophisticated investors, taking the company's cash reserves to approximately A$24 million. The lead investor in the placement was Orbis, an existing Starpharma shareholder and a highly regarded institutional fund manager. As a result of this additional investment...

2009-07-08 11:17:55

Antimicrobial treatments for bacterial vaginosis (BV) are effective, but taking lactobacillus tablets alongside metronidazole antibiotic therapy increases effectiveness over taking this antibiotic alone, according to a Cochrane Systematic Review. The researchers also concluded that intravaginal lactobacillus was as effective as oral metronidazole, although they did note unexplained drop-outs from the trials.BV is a very common vaginal infection. Traditionally, antibiotics in tablet or gel...


Latest Bacterial vaginosis Reference Libraries

72_219413818a409d6eca0e304d094c790a
2011-04-25 16:25:00

Mycoplasma genitalium is a small parasitic bacterium that lives on the ciliated epithelial cells of the primate genital and respiratory tracts. It is the smallest known free-living bacterium. Up until 2002 it was also considered to be the organism with the smallest genome. M. genitalium was isolated in 1980 from urethral specimens of two male patients with non-gonococcal urethritis. Infection is fairly common and can be transmitted between partners during unprotected sex. It can be treated...

More Articles (1 articles) »